Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Opaleye Management Inc. (CIK 1595855) reported $759.2M across 51 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: HROW ($99.9M, 13.15%), LQDA ($88.8M, 11.70%), ETON ($70.6M, 9.30%), SLGL ($39.6M, 5.22%), RYTM ($35.3M, 4.65%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | HROW | HARROW INC | $99.9M | 13.15% | 2.8M | Trimmed |
| 2 | LQDA | LIQUIDIA CORPORATION | $88.8M | 11.70% | 2.5M | Added |
| 3 | ETON | ETON PHARMACEUTICALS INC | $70.6M | 9.30% | 2.9M | Hold |
| 4 | SLGL | SOL-GEL TECHNOLOGIES LTD | $39.6M | 5.22% | 500,000 | Added |
| 5 | RYTM | RHYTHM PHARMACEUTICALS INC | $35.3M | 4.65% | 123,000 | Trimmed |
| 6 | APGE | APOGEE THERAPEUTICS INC | $32.8M | 4.32% | 390,000 | Added |
| 7 | IRON | DISC MEDICINE INC | $26.9M | 3.55% | 421,000 | Added |
| 8 | URGN | UROGEN PHARMA LTD | $25.7M | 3.39% | 1.4M | Added |
| 9 | CBIO | CRESCENT BIOPHARMA INC. | $24.1M | 3.18% | 1.3M | Added |
| 10 | STOK | STOKE THERAPEUTICS INC | $22.8M | 3.00% | 700,000 | Added |
| 11 | CATX | PERSPECTIVE THERAPEUTICS INC | $19.5M | 2.57% | 4.7M | Added |
| 12 | RZLT | REZOLUTE INC | $19.2M | 2.53% | 6.3M | Added |
| 13 | MGTX | MEIRAGTX HLDGS PLC | $18.4M | 2.42% | 2.1M | Added |
| 14 | TGTX | TG THERAPEUTICS INC | $17.8M | 2.34% | 535,000 | Hold |
| 15 | SNWV | SANUWAVE HEALTH INC | $17.0M | 2.23% | 981,267 | Hold |
| 16 | EWTX | EDGEWISE THERAPEUTICS INC | $15.8M | 2.07% | 500,000 | Hold |
| 17 | ACOG | ALPHA COGNITION INC | $14.1M | 1.85% | 2.6M | Added |
| 18 | ANNX | ANNEXON INC | $12.9M | 1.70% | 2.3M | Trimmed |
| 19 | ALMS | ALUMIS INC | $12.1M | 1.60% | 550,000 | Added |
| 20 | CDXS | CODEXIS INC | $11.1M | 1.46% | 6.8M | Trimmed |
| 21 | PTGX | PROTAGONIST THERAPEUTICS INC | $10.5M | 1.39% | 100,000 | Trimmed |
| 22 | RVMD | REVOLUTION MEDICINES INC | $9.7M | 1.28% | 100,000 | Hold |
| 23 | XOMA | XOMA ROYALTY CORPORATION | $9.4M | 1.24% | 300,000 | Added |
| 24 | QTTB | Q32 BIO INC | $8.1M | 1.06% | 1.3M | Added |
| 25 | MBX | MBX BIOSCIENCES INC | $7.8M | 1.02% | 260,000 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31